Screening of arrhythmia in early adulthood with portable 2 lead

The heart rhythm abnormality arrhythmia is commonly seen in older populations. However, arrhythmia under age 30 years is also seen in recent times. The reason for the incidence of arrhythmias is varied among the individuals based on the lifestyle changes, quality of life and genetic hereditary etc. Arrhythmia is less studied clinical condition compared to other CAD abnormalities. The detection of arrhythmia has become crucial due to its importance in management of cardiac abnormalities. The holter monitoring is the gold standard method for the detection of arrhythmia through Electrocardiogram (ECG) technique. However, the instrument is not user friendly with multiple wire tangles which results in much noise and less analysable data. The technology needs to be simplified for better screening and to take necessary actionable insights. Vigocare SmartHeart is the new generation portable, two lead biosensor solution by which advanced AV block and White Parkinson’s Syndrome was identified in the patients aged less than 30 years old. The Vigo SmartHeart biosensor solution is functioning with the combination of mobile technology. IoT based cloud for storage and AI for analysis serves utmost sensitivity for the clinical interventions.